SCHEMBL22020118

SCHEMBL22020118

CC(CO)(CO)c1ncc(S(C)(=N)=O)s1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 2/20 0.31
LOX P28300 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22012765 0.86 LOXL2 (0.33) LOXL2
SCHEMBL22012513 0.86 GCK (0.34) LOXL2
SCHEMBL24499800 0.82 LOXL2 (0.34) LOXL2LOX
SCHEMBL22021512 0.77 PTGS2 (0.32) LOXL2
SCHEMBL22013696 0.74 PTGS2 (0.31)
SCHEMBL22020730 0.73 FFAR2 (0.36) LOXL2LOX
SCHEMBL22021271 0.73 GCK (0.36) LOXL2
SCHEMBL22013608 0.73 GCK (0.36) LOXL2
SCHEMBL30243995 0.73 GCK (0.36) LOXL2
SCHEMBL21962597 0.69 GCK (0.37) LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed